Legal Representation
Attorney
Joyce M. Ferraro
USPTO Deadlines
Next Deadline
191 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
February 06, 2026
Extension Available
Until August 06, 2025
Application History
35 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 11, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 10, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Mar 10, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Mar 10, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 12, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Aug 12, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Aug 12, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Aug 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 6, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jul 1, 2024 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
Jul 1, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jul 1, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Jul 1, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jul 1, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jun 11, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 11, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 22, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 7, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 22, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Apr 22, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 22, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 22, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Mar 26, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Mar 26, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Mar 26, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Mar 11, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 11, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 11, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jan 2, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jan 2, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jan 2, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jan 2, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 10, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
May 9, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 18, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products and preparations to treat cancer and bladder diseases; gene-based pharmaceutical products and preparations to treat cancer and bladder diseases
Additional Information
Design Mark
The mark consists of of the stylized wording "ADSTILADRIN" in black. Four stylized arrows arranged in a semicircle and pointing inwards appear to the left of the first "A." Counting clockwise, the first three arrows are in a blue gradient and the fourth arrow is in a yellow gradient.
Color Claim
The color(s) black, blue, and yellow is/are claimed as a feature of the mark.
Classification
International Classes
005